Skip to main content
LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.800
+0.270 (10.67%)
Nov 21, 2024, 11:23 AM EST - Market open

LakeShore Biopharma Revenue

In the fiscal year ending March 31, 2024, LakeShore Biopharma had annual revenue of 573.42M CNY, down -16.56%. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.

Revenue (ttm)
573.42M CNY
Revenue Growth
-16.56%
P/S Ratio
0.35
Revenue / Employee
756,488 CNY
Employees
758
Market Cap
53.43M undefined

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024573.42M-113.78M-16.56%
Mar 31, 2023687.20M184.25M36.63%
Mar 31, 2022502.95M245.93M95.69%
Mar 31, 2021257.02M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LSB News

More News